AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- AnaBios, a preclinical contract research organization that provides ex vivo human platforms to de-risk new drugs, today announced a technology transfer...